• Connect with us
    • Information
      • About Us
      • Contact Us
      • Careers
      • Partnerships
      • Advertise With Us
      • Authors
      • Browse Topics
      • Events
      • Disclaimer
      • Privacy Policy
    • Australia
      North America
      World
    Login
    Investing News NetworkYour trusted source for investing success
    • North America
      Australia
      World
    • My INN
    Videos
    Companies
    Press Releases
    Private Placements
    SUBSCRIBE
    • Reports & Guides
      • Market Outlook Reports
      • Investing Guides
    • Button
    Resource
    • Precious Metals
    • Battery Metals
    • Base Metals
    • Energy
    • Critical Metals
    Tech
    Life Science
    Cannabis Market
    Cannabis News
    Cannabis Stocks
    • Cannabis Market
    • Cannabis News
    • Cannabis Stocks
    cannabis investing

    Rejected Super Bowl Cannabis Commercial Surfaces on YouTube

    Bryan Mc Govern
    Jan. 24, 2019 04:25PM PST
    Cannabis Investing News
    CSE:ACRGplay icon

    The commercial from Acreage Holdings depicts three medical marijuana patients using products to treat seizures and for pain management.

    After getting denied for an ad spot during the Super Bowl, a commercial advocating for marijuana legalization was published online.

    The 60-second tv spot was created by Acreage Holdings (CSE:ACRG), a multi-state operator (MSO) of cannabis assets in the US, as a way to launch a campaign asking for the full legalization in the US.

    “Please call your US representative or US senator to advocate for change now,” the commercial, which was uploaded to YouTube, read near the end.

    The video has over 50,000 views at the time of this writing and was published on Thursday (January 24).

    The commercial was officially rejected from airing by the CBS Corporation (NYSE:CBS), the network with the rights to this year’s Super Bowl, according to Acreage.

    The ad depicts three cases of medical marijuana patients using products for the the treatment of seizures, as an opioid replacement and for pain management.

    In a statement emailed to the Investing News Network, Kevin Murphy, CEO of Acreage, said the commercial was made to advocate for offering patients cannabis medicine.

    “We chose to launch the campaign on the nation’s greatest stage – the Super Bowl,” said Murphy. “CBS’ decision to reject the campaign represents the exact issue we are tackling – that federal law translates to no access to the medicine or even education about it.”

    As one of the most watched television events of the year, the Super Bowl attracted 103.4 million viewers last year according to Variety.

    Sports Illustrated reported an NBC Sports executive saying the average cost for a 30-second commercial during last year’s Super Bowl was over US$5 million.

    “It’s hard to compete with the amount of attention something gets when it airs during the Super Bowl,” Acreage president George Allen told Bloomberg.

    Don’t forget to follow us @INN_Cannabis for real-time news updates!

    Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.

    cannabis investingcse:acrgkevin murphy
    The Conversation (0)

    Latest News

    More News

    Outlook Reports

    Resource
    • Precious Metals
      • Gold
      • Silver
    • Battery Metals
      • Lithium
      • Cobalt
      • Graphite
    • Energy
      • Uranium
      • Oil and Gas
    • Base Metals
      • Copper
      • Nickel
      • Zinc
    • Critical Metals
      • Rare Earths
    • Industrial Metals
    • Agriculture
    Tech
      • Artificial Intelligence
      • Cybersecurity
      • Gaming
      • Cleantech
      • Emerging Tech
    Life Science
      • Biotech
      • Cannabis
      • Psychedelics
      • Pharmaceuticals

    Featured Cannabis Investing News Stocks

    extractX

    More featured stocks

    Browse Companies

    Resource
    • Precious Metals
    • Battery Metals
    • Energy
    • Base Metals
    • Critical Metals
    Tech
    Life Science
    MARKETS
    COMMODITIES
    CURRENCIES
    ×